Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Milacemide
Подписчиков: 0, рейтинг: 0
Names | |
---|---|
IUPAC name
N2-Pentylglycinamide
| |
Systematic IUPAC name
2-(Pentylamino)acetamide | |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider |
|
MeSH | milacemide |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C7H16N2O | |
Molar mass | 144.218 g·mol−1 |
log P | 0.754 |
Related compounds | |
Related compounds
|
Tricine |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Milacemide (INN) is an MAO-B inhibitor and glycine prodrug. It has been studied for its effects on human memory and as a potential treatment for the symptoms of Alzheimer's disease. Early clinical trials did not show positive results however, and the drug is now abandoned and it is sold as a nonprescription drug or supplement. While milacemide is not an amino-acid, it acts similarly to glycine in the brain.
Receptor (ligands) |
|
||||
---|---|---|---|---|---|
Transporter (blockers) |
|
||||
AMPAR |
|
---|---|
KAR |
|
NMDAR |
|